ABSTRACT
Almost all human diseases are the result of inappropriate protein production or due to the disordered protein performance. Traditional drugs are designed to interact with protein molecules throughout the body that support or cause diseases. Many severe and debilitating diseases (e.g., diabetes, hemophilia, cystic brosis) and several chronic diseases (i.e., hypertension, ischemic heart disease, asthma, Parkinson’s disease, motor neuron disease, multiple sclerosis), remain inadequately treated by conventional small molecular weight and protein drugs.
